Status:
COMPLETED
Non-interventional Observation of Practical Implementation, Efficacy and Safety of Continuous Infusion With KOGENATE Bayer in Surgery
Lead Sponsor:
Bayer
Conditions:
Hemophilia A
Eligibility:
MALE
Brief Summary
The objective of this international post-marketing surveillance study is to collect data on the efficacy and safety of continuous infusion with KOGENATE Bayer in surgery.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- In-patients with diagnosis of severe haemophilia A (FVIII \< 1%), heavily pretreated (\> 150 exposure days), without any history of inhibitors, a negative inhibitor test should be available, decision taken by the investigator to administer KOGENATE Bayer via continuous infusion during and after surgery.
Exclusion
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT00922597
Start Date
August 1 2008
End Date
September 1 2011
Last Update
April 20 2015
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Austria
2
Many Locations, Germany
3
Many Locations, Greece
4
Many Locations, Italy